{"company":{"id":3862562,"name":"PepGen","domain":"pepgen.com","url":"https://alion.io/company/pepgen"},"section":"news","answer":"PepGen: 9 headlines on record, 0 headlines in the last 90 days. Its story counts 2 milestones.","figures":[{"label":"Headlines","value":"9"},{"label":"In 90 days","value":"0"},{"label":"Milestones","value":"2"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":9},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":2}],"news":[{"date":"2026-08-07","kind":"Press release","title":"PepGen Advances PGN-EDODM1 Trial and Strengthens Finances","source":"The Globe and Mail","url":"https://theglobeandmail.com/investing/markets/stocks/PEPG-Q/pressreleases/3717820/pepgen-advances-pgn-edodm1-trial-and-strengthens-finances/"},{"date":"2026-05-20","kind":"News","title":"PepGen (PEPG) Loses 14.3% in 4 Weeks, Here","source":"YahooFinance","url":"https://finance.yahoo.com/markets/stocks/articles/pepgen-pepg-loses-14-3-133502325.html"},{"date":"2026-03-31","kind":"News","title":"PepGen crashes after mid-stage trial data for muscle disorder therapy","source":"seekingalpha.com","url":"https://seekingalpha.com/news/4570572-pepgen-posts-trial-data-muscle-disorder-drug"},{"date":"2025-09-26","kind":"News","title":"PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares","source":"YahooFinance","url":"https://finance.yahoo.com/news/pepgen-announces-closing-underwritten-public-200100114.html"},{"date":"2025-08-09","kind":"Press release","title":"Faruqi & Faruqi Reminds PepGen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - PEPG","source":"PRNewswire","url":"https://prnewswire.com/news-releases/faruqi--faruqi-reminds-pepgen-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-august-11-2025---pepg-302525423.html"},{"date":"2025-08-03","kind":"Press release","title":"PEPG Investors Have the Opportunity to Lead the PepGen Securities Fraud Lawsuit with Faruqi & Faruqi, LLP","source":"PRNewswire","url":"https://prnewswire.com/news-releases/pepg-investors-have-the-opportunity-to-lead-the-pepgen-securities-fraud-lawsuit-with-faruqi--faruqi-llp-302520029.html"},{"date":"2025-02-24","kind":"News","title":"PepGen Drug Shows Signs of Topping Rivals in Rare Muscle Disease With No Approved Meds","source":"MedCity News","url":"https://medcitynews.com/2025/02/pepgen-drug-shows-signs-of-topping-rivals-in-rare-muscle-disease-with-no-approved-meds/"},{"date":"2024-11-20","kind":"Press release","title":"PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development","source":"businesswire.com","url":"https://businesswire.com/news/home/20241121499632/en/PepGen-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4-to-Newly-Appointed-Senior-Vice-President-Clinical-Development"},{"date":"2024-05-20","kind":"News","title":"The Prognosis For PepGen","source":"seekingalpha.com","url":"https://seekingalpha.com/article/4694583-the-prognosis-for-pepgen"}],"story":[{"title":"Board appointment Heidi Henson, Director · SEC Form D","url":"https://www.sec.gov/Archives/edgar/data/1835597/000183559721000001/"},{"title":"Founded"}],"as_of":"2026-11-16","cite":"PepGen, News. Alion, Nov 16, 2026. https://alion.io/company/pepgen/news","html_url":"https://alion.io/company/pepgen/news","json_url":"https://alion.io/company/pepgen/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-16T16:46:29Z"}}